HEIDI JACKSON: Open Payments
NPI 1467486340 · MUSKEGON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,256 in 159 payments from 31 companies in 2025. Trend: 2023 $2,707 · 2024 $1,931 · 2025 $3,256
Food & beverage: $3,186Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $448 |
| GlaxoSmithKline, LLC. | 18 | $333 |
| Novo Nordisk Inc | 14 | $307 |
| Amgen Inc. | 12 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $276 |
| Teva Pharmaceuticals USA, Inc. | 11 | $271 |
| Astellas Pharma US Inc | 8 | $221 |
| PFIZER INC. | 6 | $184 |
| Lilly USA, LLC | 14 | $160 |
| Otsuka America Pharmaceutical, Inc. | 7 | $159 |
Products named: CAPLYTA, AUSTEDO XR, QULIPTA, NURTEC ODT, REXULTI, VRAYLAR, TRELEGY ELLIPTA, AREXVY.
Industry payments across MI — which companies pay providers there.
